← Back to Analyst Consensus 
GH Buy
Guardant Health, Inc.
Current Price —
Implied Upside —
Analysts 36
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 3 reiterations from 4 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 23, 2026 | Roth Capital | initiate | — → Buy | — | 53% |
| Oct 13, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Oct 7, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Oct 1, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Sep 9, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Sep 8, 2026 | Rothschild & Co | initiate | — → Buy | — | 56% |
| Sep 2, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Aug 4, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Aug 4, 2026 | Stephens & Co. | maintain | Overweight → Overweight | — | 54% |
| Aug 4, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Aug 3, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Jul 31, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 31, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jul 31, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Jul 31, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Jul 31, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 31, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jul 16, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jul 14, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 9, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Jul 8, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Jul 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Jul 6, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Jul 2, 2026 | Bernstein | maintain | Outperform → Outperform | — | 52% |
| Jul 1, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jun 29, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jun 24, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jun 11, 2026 | RBC Capital | initiate | — → Outperform | — | 55% |
| Jun 8, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jun 5, 2026 | Goldman Sachs | initiate | Buy → Buy | — | 54% |
| Jun 2, 2026 | Evercore ISI Group | upgrade | In-Line → Outperform | — | 58% |
| May 27, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| May 26, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| May 8, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| May 8, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 8, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | — | 58% |
| Apr 14, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 6, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | — | 58% |
| Feb 24, 2026 | Piper Sandler | maintain | Overweight → Overweight | $130 | 54% |
| Feb 20, 2026 | Leerink Partners | maintain | Outperform → Outperform | $180 | 51% |
| Feb 20, 2026 | Citigroup | maintain | Buy → Buy | $150 | 54% |
| Feb 20, 2026 | Canaccord Genuity | maintain | Buy → Buy | $135 | 48% |
| Feb 20, 2026 | JP Morgan | maintain | Overweight → Overweight | $130 | 54% |
| Feb 20, 2026 | TD Cowen | maintain | Buy → Buy | $135 | 54% |
| Feb 20, 2026 | Wells Fargo | maintain | Overweight → Overweight | $125 | 54% |
| Feb 20, 2026 | Stifel | maintain | Buy → Buy | $130 | 53% |
| Feb 20, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | $110 | 58% |
| Feb 20, 2026 | BTIG | maintain | Buy → Buy | $145 | 52% |
| Feb 17, 2026 | Baird | initiate | — → Outperform | $120 | 55% |
| Jan 26, 2026 | Guggenheim | maintain | Buy → Buy | $135 | 52% |
Price Target Trend
Jul 18, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days